Nasya with 0.5ml Shwadanstradi Tail in Ardhavabhedak patient of age 18 to 60 year

Randomised uncontrolled clinical study to evaluate the efficacy of Shwadanstradi Tail nasya in ardhavabhedak with special reference to Migraine - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/081686

Enrollment

Registered

2025-03-05

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G09- Sequelae of inflammatory diseasesof central nervous system

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient presenting sign and symptoms of Ardhavbhedaka like attack of headache Mostly unilateral in nature,variable in Intensity, frequency and duration with and without nausea.

Exclusion criteria

Exclusion criteria: Hypertension, DM,women under menstrual cycle, pregnant and lactating mother,women having headache 4 to 5 days before menstrual cycle.

Design outcomes

Primary

Measure	Time frame
Efficacy of Shwadanstradi Tail Nasya in ArdhavabhedakTimepoint: 7 Days	—

Secondary

Measure	Time frame
To study Shwadanshtradi Tail To study ArdhavabhedakTimepoint: 7 Days	—

Countries

India

Contacts

Public ContactMrunali Ramchandra Gavade

LKR Ayurvedic college and Research center

drsachinayurved@gmail.com9823347244

Outcome results